institutional
SN
NASDAQ · SNY
Sanofi
Healthcare · Drug Manufacturers - General
$42.40
Up+$0.31 (+0.72%)
Updated Sep 16, 2026, 2:00 PM
SID Score
6.2/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 119.04B
- P/E ratio
- 11.2
- Dividend yield
- 5.22%
- 52-week range
- $40.89 – $52.68
- Volume
- 2.68M
- Avg. volume
- 2.95M
Price performance
SNY price history
1M range · 20 trading sessions · Daily adjusted prices
SNY closed at $42.40 after 20 trading sessions, down 5.71% for the selected period.
- Last close
- $42.40
- Period change
- -5.71%
- Period low
- $42.40
- Period high
- $46.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $42.78 | $42.89 | $42.38 | $42.40 | 2.68M |
| Sep 14, 2026 | $43.70 | $43.74 | $43.015 | $43.33 | 2.33M |
| Sep 11, 2026 | $42.81 | $42.885 | $42.41 | $42.77 | 2.37M |
| Sep 10, 2026 | $42.86 | $43.05 | $42.67 | $42.72 | 1.96M |
| Sep 9, 2026 | $43.08 | $43.46 | $42.8205 | $42.85 | 1.95M |
| Sep 8, 2026 | $43.49 | $43.71 | $43.14 | $43.155 | 2.6M |
| Sep 4, 2026 | $44.17 | $44.36 | $44.025 | $44.24 | 1.7M |
| Sep 3, 2026 | $45.15 | $45.16 | $44.20 | $44.33 | 2.4M |
| Sep 2, 2026 | $44.68 | $45.22 | $44.43 | $44.47 | 2.17M |
| Sep 1, 2026 | $45.08 | $45.23 | $44.205 | $44.37 | 2.02M |
| Aug 31, 2026 | $44.59 | $44.69 | $44.26 | $44.36 | 2.35M |
| Aug 28, 2026 | $44.93 | $44.96 | $44.65 | $44.82 | 1.36M |
| Aug 27, 2026 | $44.86 | $45.08 | $44.72 | $44.84 | 2.29M |
| Aug 26, 2026 | $46.01 | $46.04 | $45.39 | $45.42 | 1.63M |
| Aug 25, 2026 | $45.73 | $46.05 | $45.57 | $46.02 | 1.24M |
| Aug 24, 2026 | $45.49 | $45.78 | $45.32 | $45.69 | 1.72M |
| Aug 21, 2026 | $45.26 | $46.11 | $45.25 | $45.85 | 1.86M |
| Aug 20, 2026 | $45.65 | $45.74 | $45.06 | $45.15 | 2.6M |
| Aug 19, 2026 | $45.42 | $46.02 | $45.42 | $45.83 | 2.74M |
| Aug 18, 2026 | $45.10 | $45.22 | $44.735 | $44.97 | 3.17M |
Latest SNY news
The latest Smart Investors Daily articles mentioning SNY.
Stock researchCompany · Financials
Loading stock research…

